Office-based management of nonmuscle invasive bladder cancer.

Overview

Bladder cancer is extremely common in the United States and extremely costly because of the high cost of surveillance. In some patients, office-based surveillance may be a safe, cost-reducing alternative. This article attempts to identify ideal candidates and highlights surveillance strategies that can be employed in an office-based setting.